9999999997-17-000034.txt : 20170105 9999999997-17-000034.hdr.sgml : 20170105 20170105120424 ACCESSION NUMBER: 9999999997-17-000034 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 20170105 20170105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-194442 FILM NUMBER: 17509606 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-996-4300 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end